Alvin Lee
Consultant medical oncologist
Biography
Alvin Lee is a consultant medical oncologist at Guy's and St Thomas' NHS Foundation Trust, specialising in skin cancers (melanoma).
He joined as a consultant in 2024 and combines his clinical role with work as a medical advisor at the Cancer Research UK Centre for Drug Development, helping to guide the development of novel cancer therapies.
He completed his oncology training within the University College London rotations and gained translational research experience in Cambridge, Oxford and London including a clinical postdoctoral fellowship at the Francis Crick Institute.
Education and training
- Medical oncology training as NIHR clinical lecturer, University College London
- Medical training in Oxford, including research as part of Academic Foundation Programme, University of Oxford
- ESMO examination certificate in medical oncology
- Specialty certificate examination (SCE) in medical oncology MRCP (UK)
- Bachelor of medicine, bachelor of surgery (MB BS), University College London
- PhD (MB PhD), University College London
- MA natural sciences/medical sciences, University of Cambridge
- PGCert leading clinical research delivery, University of Exeter
- PGCert oncology, Newcastle University
- PGCert medical education, University of Dundee
- PGCert genomic medicine, Imperial College
Research interests
- Clinical trials
- Drug development
Awards
- Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) - 2024
- Fellow of the Royal Society of Biology (FRSB) - 2024
- Fellow qua Physician of the Royal College of Physicians and Surgeons of Glasgow (FRCP Glasg) - 2023
- Innovative Protocol Award, EORTC-ESMO-AACR Workshop on Methods in Clinical Cancer Research (MCCR) - 2022
- International Poster Award, Korean Cancer Association Meeting - 2021
- Cordwainers’ Prize for best thesis, UCL MB PhD Programme - 2012
Contact
Email: [email protected]
Specialist interests
- Melanoma (skin cancer)
- Drug development
- Early-phase and translational clinical trials
Last updated: November 2025